CompletedNCT01710709
This study is completed in the United States, in France, in Canada, .... It is testing an Intramuscular Formulation of Aripiprazole for Bipolarity.
Multiple locations, including BirminghamBipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States, France, Canada, ...
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Bipolarity
CompletedNCT04292223
This study is completed in the United States. It focuses on Schizophrenia.
Multiple locations, including ScottsdaleSchizophreniaOtherOver 40 Years
- Countries
- United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
CompletedNCT06319170
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Los AlamitosSchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Condition
- Schizophrenia
CompletedNCT00421954
This study is completed in the United States. It focuses on Schizophrenia.
In New YorkSchizophrenia, Depression, ...OtherFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Schizophrenia, Depression, ...
CompletedNCT00723190
This study is completed in the United States. It is testing CLONICEL (Clonidine HCl Sustained Release) for ADHD.
Multiple locations, including Little RockADHDOtherFrom 6 Years to 17 Years
- Countries
- United States
- Sponsor
- Shionogi
- Condition
- ADHD
CompletedNCT01416064
This study is completed in the United States. It focuses on ADHD.
Multiple locations, including DothanADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Condition
- ADHD
CompletedNCT04578756
This study is completed in the United States. It is testing cariprazine for schizophrenia.
Multiple locations, including DothanBipolarity, SchizophreniaOtherFrom 5 Years to 17 Years
- Countries
- United States
- Sponsor
- AbbVie
- Condition
- Bipolarity, Schizophrenia
CompletedNCT04081363
This study is completed in the United States. It focuses on ADHD.
In New YorkADHDOtherFrom 9 Years to 12 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
OngoingEUCTR 2022-001582-12
This study is ongoing in Spain. It is testing aripiprazole vs paliperidone / risperidone using multi-omics data for Schizophrenia.
In SpainSchizophreniaOther
- Countries
- Spain
- Sponsor
- Consorcio Centro de Investigacion Biomedica en Red (CIBER)
- Condition
- Schizophrenia
Enrolling By InvitationNCT06512324
This study is enrolling by invitation. It focuses on depression and currently lists participation information in the United States.
Multiple locations, including EncinitasDepression, AnxietyDeviceA study involving a tool, app, wearable, test, or medical device.Over 12 Years
- Countries
- United States
- Sponsor
- Biomedical Discoveries and Neuroscientific Foundations LLC
- Condition
- Depression, Anxiety
Active Not RecruitingNCT04116528
This study is active but not recruiting. It focuses on depression and currently lists study information in the United States.
In StanfordDepressionDrugA study involving a medication or substance.From 18 Years to 70 Years
- Countries
- United States
- Sponsor
- Stanford University
- Condition
- Depression
CompletedNCT03889418
This study is completed. It focuses on anxiety and currently lists study information in the United States.
In New OrleansAnxiety, DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- Ochsner Health System
- Condition
- Anxiety, Depression
